PARG-IN-4

Overview

PARG-IN-4 (Formula (A)) is an orally available PARG inhibitor (EC50=1.9 nM) with cell membrane permeability. PARG-IN-4 can effectively inhibit tumor growth in mouse models. PARG-IN-4 can be used in cancer research.

Application

Products | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Poly(ADP-ribose) Glycohydrolase (PARG) | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-156881
• CAS No.: 2988890-20-4
• Molecular Formula: C20H25F2N7O2S2
• Molecular Weight: 497.59
• Purity: 98.50%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: 2 mg/mL (4.02 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source